Sol-Gel Technologies Ltd. (SLGL)
53.45
+0.62
(+1.17%)
USD |
NASDAQ |
Nov 18, 16:00
54.08
+0.63
(+1.18%)
After-Hours: 20:00
Sol-Gel Technologies Enterprise Value : 129.48M for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 129.48M |
| November 16, 2026 | 136.46M |
| November 13, 2026 | 136.98M |
| November 12, 2026 | 140.68M |
| November 11, 2026 | 164.11M |
| November 10, 2026 | 157.89M |
| November 09, 2026 | 158.67M |
| November 06, 2026 | 156.28M |
| November 05, 2026 | 162.83M |
| November 04, 2026 | 172.63M |
| November 03, 2026 | 165.45M |
| November 02, 2026 | 171.61M |
| October 30, 2026 | 180.33M |
| October 29, 2026 | 181.34M |
| October 28, 2026 | 179.77M |
| October 27, 2026 | 179.80M |
| October 26, 2026 | 184.52M |
| October 23, 2026 | 183.93M |
| October 22, 2026 | 177.18M |
| October 21, 2026 | 171.71M |
| October 20, 2026 | 172.01M |
| October 19, 2026 | 169.29M |
| October 16, 2026 | 166.90M |
| October 15, 2026 | 181.48M |
| October 14, 2026 | 184.10M |
| Date | Value |
|---|---|
| October 13, 2026 | 180.17M |
| October 12, 2026 | 193.60M |
| October 09, 2026 | 191.53M |
| October 08, 2026 | 186.85M |
| October 07, 2026 | 192.11M |
| October 06, 2026 | 204.21M |
| October 05, 2026 | 215.06M |
| October 02, 2026 | 192.29M |
| October 01, 2026 | 195.56M |
| September 30, 2026 | 199.76M |
| September 29, 2026 | 189.39M |
| September 28, 2026 | 180.22M |
| September 25, 2026 | 171.71M |
| September 24, 2026 | 151.70M |
| September 23, 2026 | 148.33M |
| September 22, 2026 | 152.39M |
| September 21, 2026 | 146.92M |
| September 18, 2026 | 149.28M |
| September 17, 2026 | 164.14M |
| September 16, 2026 | 160.54M |
| September 15, 2026 | 163.69M |
| September 14, 2026 | 166.24M |
| September 11, 2026 | 168.73M |
| September 10, 2026 | 171.51M |
| September 09, 2026 | 179.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 62.64B |
| RedHill Biopharma Ltd. | -11.74M |
| MediWound Ltd. | 158.09M |
| Purple Biotech Ltd. | -3.262M |
| PolyPid Ltd. | 123.72M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.622M |
| Revenue (Quarterly) | 0.041M |
| Total Expenses (Quarterly) | 5.663M |
| EPS Diluted (Quarterly) | -1.716 |
| Profit Margin (Quarterly) | -13.71K% |
| Earnings Yield | -9.78% |
| Normalized Earnings Yield | -9.780 |